Literature DB >> 31198169

Utility of a urine sediment score in hyperbilirubinemia/hyperbilirubinuria
.

José A T Poloni, Mark A Perazella, Elizete Keitel, Claudio A Marroni, Samantha B Leite, Liane N Rotta.   

Abstract

AIMS: Acute and chronic kidney dysfunction is common in patients with end-stage liver disease. Differentiation between acute kidney injury (AKI) due to hepatorenal syndrome (HRS) or acute tubular necrosis (ATN) remains difficult, however urine cast scoring systems using renal tubular epithelial cells (RTECs) and granular casts (GCs) can help to identify intrinsic kidney diseases. The objective of this study was to evaluate the urine sediment profile of patients with liver disease and hyperbilirubinemia/hyperbilirubinuria and the use of a urine sediment scoring system to identify the most common score in AKI patients and high urine bilirubin concentrations.
MATERIALS AND METHODS: A retrospective study in the database of a large laboratory that assists a hospital-complex in Brazil was performed.
RESULTS: Urinary casts, in particular GCs, as well as RTECs were observed more frequently in patients with hyperbilirubinemia/hyperbilirubinuria, while hyaline casts were observed in patients without hyperbilirubinemia/hyperbilirubinuria. Regardless of the AKI or non-AKI condition, the relative risk for scores 2 or 3 (sediment consistent with tubular damage, with GCs and/or RTECs in different quantities) in group 4 was 3.61 times higher compared to patients in group 1.
CONCLUSION: In patients with higher urinary bilirubin levels, the urine sediment had greater numbers of GCs and RTECs and higher urine sediment scores (scores 2 or 3). The presence of a larger number of urine particles (RTECs and GCs) originating in the kidneys in the groups with higher levels of urinary bilirubin suggests an association between hyperbilirubinemia/hyperbilirubinuria and tubular injury independent of AKI or non-AKI.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31198169     DOI: 10.5414/CN109673

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

Review 1.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

2.  Diagnostic Utility of Serial Microscopic Examination of the Urinary Sediment in Acute Kidney Injury.

Authors:  Vipin Varghese; Maria Soledad Rivera; Ali A Alalwan; Ayman M Alghamdi; Manuel E Gonzalez; Juan Carlos Q Velez
Journal:  Kidney360       Date:  2020-12-11

Review 3.  Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy.

Authors:  Juan Carlos Q Velez
Journal:  Kidney360       Date:  2021-12-03

4.  Diagnostic value of urinary microprotein concentration for patients with negative urinary protein test results and positive urinary casts on microscopic examination.

Authors:  ChunSheng Zheng; WenHua Wang; RongYan Chen; JiLai Liu; YangYu Li; XueJun Qin
Journal:  J Clin Lab Anal       Date:  2020-07-19       Impact factor: 2.352

Review 5.  Hepatorenal syndrome in acute-on-chronic liver failure with acute kidney injury: more questions requiring discussion.

Authors:  Songtao Liu; Qinghua Meng; Yuan Xu; Jianxin Zhou
Journal:  Gastroenterol Rep (Oxf)       Date:  2021-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.